Phase II Randomized Controlled Trial of Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2018
Price : $35 *
At a glance
- Drugs Peginterferon alfa-2b (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
- 01 Nov 2017 Status changed from active, no longer recruiting to discontinued.
- 19 May 2016 Status changed from recruiting to active, no longer recruiting.
- 19 May 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017.